Showing 801 - 820 results of 16,814 for search '"cancers"', query time: 0.11s Refine Results
  1. 801
  2. 802

    Effects of awareness of breast cancer overdiagnosis among women with screen-detected or incidentally found breast cancer: a qualitative interview study by Brooke Nickel, Alexandra Barratt, Kirsten McCaffery, Kristen Pickles, Jolyn Hersch, Jayant S Vaidya

    Published 2022-06-01
    “…Objectives To explore experiences of women who identified themselves as having a possible breast cancer overdiagnosis.Design Qualitative interview study using key components of a grounded theory analysis.Setting International interviews with women diagnosed with breast cancer and aware of the concept of overdiagnosis.Participants Twelve women aged 48–77 years from the UK (6), USA (4), Canada (1) and Australia (1) who had breast cancer (ductal carcinoma in situ n=9, (invasive) breast cancer n=3) diagnosed between 2004 and 2019, and who were aware of the possibility of overdiagnosis. …”
    Get full text
    Article
  3. 803
  4. 804
  5. 805
  6. 806

    Towards a cervical cancer-free future: women’s healthcare decision making and cervical cancer screening uptake in sub-Saharan Africa by Bright Opoku Ahinkorah, Abdul-Aziz Seidu, Richard Gyan Aboagye, Bernard Yeboah-Asiamah Asare, Joshua Okyere, Bupe Mwamba

    Published 2022-07-01
    “…Objective We investigated the association between women’s healthcare decision making and cervical cancer screening uptake in sub-Saharan Africa.Design Secondary data from the Demographic and Health Surveys of six countries in sub-Saharan Africa were used. …”
    Get full text
    Article
  7. 807
  8. 808
  9. 809
  10. 810

    Tousled-like kinase loss confers PARP inhibitor resistance in BRCA1-mutated cancers by impeding non-homologous end joining repair by Min-ah Kim, Banseok Kim, Jihyeon Jeon, Jonghyun Lee, Hyeji Jang, Minjae Baek, Sang-Uk Seo, Dongkwan Shin, Anindya Dutta, Kyung Yong Lee

    Published 2025-01-01
    “…Consequently, TLK deficiency induces PARPi resistance in triple-negative breast cancer (TNBC) and ovarian cancer (OVCA) cell lines with BRCA1 deficiency, as TLK deficiency in BRCA1-depleted cells, impairs 53BP1 recruitment to DSBs and reduces NHEJ efficiency, while restoring HR. …”
    Get full text
    Article
  11. 811
  12. 812

    EU-TIRADS-Based Omission of Fine-Needle Aspiration and Cytology from Thyroid Nodules Overlooks a Substantial Number of Follicular Thyroid Cancers by Tamas Solymosi, Laszlo Hegedüs, Miklos Bodor, Endre V. Nagy

    Published 2021-01-01
    “…Whether sensitivity in identifying thyroid cancers varies with thyroid cancer phenotype remains unclarified. …”
    Get full text
    Article
  13. 813

    Therapeutic Implications of Targeting Energy Metabolism in Breast Cancer by Meena K. Sakharkar, Babita Shashni, Karun Sharma, Sarinder K. Dhillon, Prabhakar R. Ranjekar, Kishore R. Sakharkar

    Published 2013-01-01
    “…PPARγ agonists have been reported as a new and potentially efficacious treatment of inflammation, diabetes, obesity, cancer, AD, and schizophrenia. Since cancer cells show dysregulation of glycolysis they are potentially manageable through changes in metabolic environment. …”
    Get full text
    Article
  14. 814
  15. 815

    DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics by Dipanjan Bhattacharjee, Smita Shenoy, Kurady Laxminarayana Bairy

    Published 2016-01-01
    “…Thus, tweaking the epigenetic machinery may help cause or cure diseases, especially cancer. Therefore, cancer epigenetics, especially at a molecular level, needs to be scrutinised closely, as it could potentially serve as the future pharmaceutical goldmine against neoplastic diseases. …”
    Get full text
    Article
  16. 816
  17. 817
  18. 818
  19. 819

    The Current Role of Osteoclast Inhibitors in Patients with Prostate Cancer by Diomidis Kozyrakis, Dionyssios Paridis, Stefanos Perikleous, Konstantinos Malizos, Anastasios Zarkadas, Antonios Tsagkalis

    Published 2018-01-01
    “…Purpose. Prostate cancer (PCa) is one of the most frequently diagnosed malignancies worldwide. …”
    Get full text
    Article
  20. 820